ArticlePloS one2026
LXNet: A lightweight CNN for lung disease classification from Chest X-ray with XAI-based interpretability.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis of lung diseases such as pneumonia and tuberculosis remains a major global health challenge, especially in resource-limited regions. Artificial Intelligence (AI) has shown strong potential in analyzing Chest X-Rays (CXR) for accurate and timely diagnosis, but most existing models are computationally heavy and lack interpretability, limiting their practical application. In this study, we present LXNet, a lightweight and explainable Convolutional Neural Network (CNN) for nine-class lung disease classification (Normal, Pneumonia, Higher Density, Lower Density, Obstructive Pulmonary Diseases, Degenerative Infectious Diseases, Encapsulated Lesions, Mediastinal Changes and Chest Changes). The model was evaluated on a diverse CXR dataset containing 6,743 images collected from a private imaging center (GRS Imagem, Brazil), enabling comprehensive multiclass assessment. LXNet contains only 0.35 million parameters and employs a no-pooling final block to preserve subtle diagnostic features while maintaining very low computational cost. Robustness was enhanced through adaptive Contrast Limited Adaptive Histogram Equalization (CLAHE), grayscale normalization and stratified class balancing. LXNet was benchmarked against pretrained CNNs (DenseNet201, ResNet50V2 and InceptionV3) under identical settings. Explainable AI (Grad-CAM, Score-CAM and LIME) provided meaningful visualizations. LXNet achieved 96.1% accuracy in 5-fold cross validation, outperforming the baselines (DenseNet201: 90.3%, InceptionV3: 88.9%) by 1-8%, with only 308 seconds of training on standard hardware. Statistical significance was confirmed using Wilcoxon signed-rank tests (p = 0.03125). These results demonstrate LXNet's promising performance and interpretability; however, reduced external performance indicates limited generalizability and its clinical applicability requires further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.